SEARCH HEALTH CONDITIONS BY ALPHABETS

Acute Myeloblastic Leukemia



Medications for Acute Myeloblastic Leukemia

About Acute Myeloblastic Leukemia:  Acute Myeloblastic Leukemia can be known as Acute Myeloid Leukemia. It`s cancer which starts inside bone marrow, the soft tissue in bones that helps form blood cells. The cancer develops from cells which will normally turn to white blood cells.

Drugs Used to Treat Acute Myeloblastic Leukemia

This set of medications come used in the treating this illness, or in some way associated with.

Drug title Rx / OTC Pregnancy CSA AlcoholReviewsRatingPopularity
doxorubicinRx D N Add review
0.0

Generic name: doxorubicin systemic

Brand name:  Adriamycin

Drug course: antibiotics/antineoplastics

For consumers: dosage, interactions,

For specialists: a Z Drug Facts, AHFS DI Monograph, Prescribing Information

AdriamycinRx D N Add review
0.0

Generic name: doxorubicin systemic

Drug course: antibiotics/antineoplastics

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Legend

RxPrescription Only
OTCOn The Counter
Rx/OTCPrescription or Over the Counter
Away Tag This drug might not be approved by the FDA for treating this illness.
Pregnancy Category
AAdequate and well-controlled studies have failed to demonstrate a risk to the embryo in the first trimester of pregnancy (and there isn`t any evidence of risk in later trimesters).
BAnimal reproduction studies have failed to show a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
CAnimal reproduction studies have shown a negative effect on the fetus and there are no adequate and well-controlled studies in humans, but possible benefits may warrant used in pregnant women despite potential risks.
Dthere was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but possible benefits may warrant used in pregnant women despite potential risks.
XStudies in animals or humans have demonstrated fetal abnormalities or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved with used in pregnant women obviously outweigh potential gains.
NFDA have not classified this drug.
Controlled Substances Act (CSA) Program
NIs not at the mercy of the Controlled Substances Act.
1Has a higher potential for abuse. Has no accepted medical use in treatment in the USA. There`s a lack of accepted safety for use under medical supervision.
2Has a higher potential for abuse. Includes a currently accepted medical use in treatment in the USA or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependency.
3includes a possibility for abuse less than those in programs 1 and 2. Includes a currently accepted medical use in treatment in the USA. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4Has a very low potential for abuse in accordance with those in program 3. It has a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence.
5Has a very low potential for abuse in accordance with those in program 4. Includes a currently accepted medical use in treatment in the USA. Abuse can lead to limited physical dependence or psychological dependence relative to individuals in program 4.
Alcohol
XInteracts with Medication.

Browse Treatment Options

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • Runciman
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Further information

Always consult your physician to ensure the information displayed on this page pertains to your personal circumstances.



Top USA Pharma Companies